ANXA1 and nasopharyngeal carcinoma: The results showed that downregulation of either of the two proteins resulted in a significant reduction of LC3-II and EGFP-LC3 puncta levels in the ANXA1 KD NPC cells, but had not obvious effect on the levels of LC3-II and EGFP-LC3 puncta in the scramble shRNA control cells (Fig. 2e).